History of bladder cancer status post cystectomy. Evaluate for metastatic disease. ABDOMEN:LIVER, BILIARY TRACT: The liver is normal in morphology, size, signal intensity and enhancement without a suspicious lesion. No biliary ductal dilatation or vascular abnormality. No intra or extrahepatic biliary ductal dilatation. Normally distended gallbladder.SPLEEN: Spleen is normal in morphology, size, signal intensity and enhancement.PANCREAS: The pancreas is normal in morphology and enhancement without a focal lesion or pancreatic ductal dilatation.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Status post left nephrectomy. No evidence of tumor recurrence in the nephrectomy bed. No locoregional lymphadenopathy.Nonspecific striated early arterial enhancement of the right kidney with wedge-shaped regions of hypoattenuation which fill in on more delayed imaging without an underlying suspicious lesion. Small stable and new subcentimeter cysts.RETROPERITONEUM, LYMPH NODES: No enlarged retroperitoneal lymph nodes.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.PELVIS:PROSTATE/SEMINAL VESICLES: Status post cystoprostatectomy.BLADDER: Status post cystoprostatectomy with neobladder formation.LYMPH NODES: Solidly enhancing left pelvic nodule measures approximately 1.6 x 1.0 cm (series 11/63), unchanged from the prior.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: Stable nonspecific 6 mm enhancing focus in the right sacral ala is unchanged (series 11/36). OTHER: No significant abnormality noted.
1.Stable solidly enhancing left pelvic 1.6 cm lesion.2.Striated early enhancement of the right kidney without a discrete suspicious lesion.3.No new sites of disease.